Use of Kinase Inhibitors to Illuminate Signaling Pathways in Breast Cancer
In the United States, breast cancer is the most commonly diagnosed cancer and is the second most common cause of cancer-related deaths among women. Among the various subtypes of breast cancer, 25-30% of diagnoses present themselves as human epidermal growth factor receptor 2 positive (HER-2+). HER-2...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Published: |
Virginia Tech
2019
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10919/92002 |